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The ancestral retinoic acid receptor was a low-affinity
sensor triggering neuronal differentiation
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Keely Pierzchalski,6 Jace W. Jones,6 Ricard Albalat,7 Maureen A. Kane,6 William Bourguet,4
Vincent Laudet,2‡§¶ Detlev Arendt,1,8‡¶ Michael Schubert9‡¶
Retinoic acid (RA) is an important intercellular signaling molecule in vertebrate development, with a well-
established role in the regulation of hox genes during hindbrain patterning and in neurogenesis. However,
the evolutionary origin of the RA signaling pathway remains elusive. To elucidate the evolution of the RA
signaling system, we characterized RA metabolism and signaling in the marine annelid Platynereis dumerilii,
a powerful model for evolution, development, and neurobiology. Binding assays and crystal structure analyses
show that the annelid retinoic acid receptor (RAR) binds RA and activates transcription just as vertebrate RARs,
yet with a different ligand-binding pocket and lower binding affinity, suggesting a permissive rather than in-
structive role of RA signaling. RAR knockdown and RA treatment of swimming annelid larvae further reveal that
the RA signal is locally received in the medial neuroectoderm, where it controls neurogenesis and axon
outgrowth, whereas the spatial colinear hox gene expression in the neuroectoderm remains unaffected. These
findings suggest that one early role of the new RAR in bilaterian evolution was to control the spatially restricted
onset of motor and interneuron differentiation in the developing ventral nerve cord and to indicate that the
regulation of hox-controlled anterior-posterior patterning arose only at the base of the chordates, concomitant with




In vertebrates, retinoic acid (RA) regulates a wide range of biological
processes in development and adult life. During embryogenesis, RA
controls patterning along the anteroposterior body axis and is required
for the proper formation of various organs, including heart, liver,
kidney, limbs, and the nervous system (1, 2). In the developing central
nervous system, RA mediates anteroposterior regionalization via the
direct control of hox transcription and subsequently stimulates neuro-
genesis and promotes neuronal differentiation via the activation of
pax6, ngn2, and dbx1 in specific regions of the neuroectoderm (1, 2).ay 8, 2019In vivo, RA is synthesized from vitamin A in two different oxida-
tive steps. The first one, the rate-limiting dehydrogenation of retinol to
retinal, is catalyzed by retinol dehydrogenases (RDHs) of the short- or
medium-chain dehydrogenase/reductase superfamilies [for example,
SDR-RDH10 or MDR-ADH3 (alcohol dehydrogenase 3)] (3). Alter-
natively, retinal can be further produced from the enzymatic cleavage
of b-carotene by carotenoid cleavage oxygenase (CCO) enzymes. The
second step, the production of RA from retinal, is catalyzed by the
retinaldehyde dehydrogenases (RALDHs). Although different isomers
of RA exist, such as all-trans RA (ATRA), 9-cis RA (9cRA), and 13-cis
RA (13cRA), the most important biologically active RA isomer in ver-
tebrates is ATRA (3, 4).
The major mediators of RA signaling are the retinoic acid receptor
(RAR) and the retinoid X receptor (RXR), which are ligand-dependent
transcription factors belonging to the nuclear receptor superfamily.
RAR and RXR heterodimerize on specific DNA stretches, called RA re-
sponse elements (RAREs), present in the promoter regions of target
genes (5–7). The RAR ligand-binding domain (LBD) mediates the
high-affinity binding of ATRAwith a dissociation constant in the nano-
molar range (Kd = 0.4 nM) (8). The LBD contains 12 helices that form
the ligand-binding pocket (LBP) (9), and binding of the ligandmodifies
the position of helix 12, allowing the recruitment of coactivators. This
association of coactivators, in turn, leads to the initiation of transcription
of RA target genes (7, 10, 11).
Although RA signaling is traditionally described as a chordate inno-
vation, key elements of the RAmachinery, such as RAR and RXR, have
been identified in several nonchordate genomes (12, 13). For example,
genes encoding RAR, RXR, and RALDH, as well as the RA-catabolizing
enzyme CYP26 (cytochrome P450 subfamily 26), have been identi-
fied in the annelid Capitella teleta (12, 13). In contrast, in the annelid
Helobdella robusta, RAR and CYP26 have been lost (13), and the only
report of roles of RA in annelids assessed the effects of very high con-
centrations of retinal on juvenile and regenerating worms (14).1 of 16






Furthermore, the functional characterization of RARs from two gastropod
mollusks, Thais clavigera andNucella lapillus, has established that these re-
ceptors are unable to bindRA (15, 16). Therefore, albeit the presence of the
main RA signaling components in various bilaterian taxa, RAR-dependent
RA signaling still retains its status as a chordate-specific feature.
Here, we describe the characterization of a novel RAR cloned from
the annelid Platynereis dumerilii. We show that the P. dumerilii RAR
(PduRAR) acts as ligand-activated transcription factor in the presence
of ATRA and 13cRA, both of which are present in embryos, larvae, and
adults. However, RA activates the annelid receptor only in the micro-
molar range, indicating that PduRAR is a low-affinity RA sensor and
not a chordate-type high-affinity RAR. Furthermore, the crystal struc-
ture of the PduRAR LBD reveals that differential binding of RA mole-
cules to the LBPs of the P. dumerilii and vertebrate receptors defines the
structural basis for these affinity differences. During development,
PduRAR does not control anteroposterior patterning of the embryo
and does not regulate hox gene expression. In contrast, RA signaling
functions during annelid neurogenesis to control differentiation and ax-
onal outgrowth of medial neuron types in the ventral nerve cord. Our
work is the first to unravel RAR function outside chordates and suggests
that one early role of RAR-dependent RA signaling was the spatio-
temporal control of motor and interneuron differentiation. Our com-
parative data indicate that the ancestral RAR likely acted as a permissive
sensor and that high-affinity, instructive RARs evolved only at the base
of chordates, concomitant with a role for RA signaling in global antero-
posterior patterning through hox gene regulation.dvances.sciencem
ag.orgRESULTS
Identification of RA signaling pathway components in
P. dumerilii
To gain insights into the evolution of the RA pathway, we screened tran-
scriptomic and genomic databases of the marine annelid P. dumerilii
(17) for molecular components characterizing chordate RA signalingHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018(3). These included genes encoding the nuclear receptors RAR and
RXR, enzymes involved in RA synthesis and degradation [CCO,
SDR, MDR, RALDH—that is, members of the aldehyde dehydrogenase
1a (ALDH1a) and ALDH8a subfamilies—and CYP26], retinoid tran-
sport proteins and plasma membrane–associated receptors [cellular
RA-binding protein (CRABP), cellular retinol-binding protein (CRBP),
retinol-binding protein 4 (RBP4), transthyretin (TTR), and stimulated
by RA 6 (STRA6)], and enzymes involved in the synthesis and deg-
radation of retinoid storage products [lecithin-retinol acyltransferase
(LRAT), acyl-CoA:retinol acyltransferase (DGAT), and retinoid iso-
merohydrolase (RPE65)] (Fig. 1).
Phylogenetic analyses of the obtained gene sequences allowed us to
identify single rar and rxr homologs in P. dumerilii. Furthermore, we
characterized five aldh1a, one aldh8a, three cyp26, one sdr-rdh10, one
mdr-adh3, and three cco genes, demonstrating that the basic RA
signaling machinery, composed of receptors as well as RA-synthesizing
and RA-degrading enzymes, is present in P. dumerilii (Fig. 1 and fig.
S1). A vertebrate-type RA metabolism and RAR-dependent signaling
were thus already present at the base of bilaterians.
To maintain retinoid homeostasis, vertebrates can accumulate reti-
noids in the liver and mobilize them to satisfy the RA requirements of
peripheral tissues. Retinol is esterified to retinyl esters by the action of
the vertebrate LRAT or DGAT1 enzymes, and retinyl esters can be
transformed back to retinol by retinyl ester hydrolases (including
RPE65) (18). P. dumerilii seems to lack lrat and rpe65 orthologs, al-
though an ortholog of dgat has been identified in P. dumerilii, suggest-
ing that de novo synthesis of retinyl esters is possible (Fig. 1 and fig. S1).
Retinoids are generally bound to proteins that solubilize and stabilize
them in aqueous environments. P. dumerilii lacks homologs of the typ-
ical vertebrate retinoid binding proteins, that is, of the intracellular crbp
and crabp, as well as of the extracellular rbp4 and ttr. Concomitantly,
stra6, the membrane receptor required for rbp4-dependent retinol
uptake into target cells in vertebrates (3), is also absent fromP. dumerilii.
These data suggest that, although the core components of the RA on M
ay 8, 2019
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Fig. 1. Molecular components of retinoid metabolism and signaling. Schematic representation of retinoid metabolism, storage, transport, and signaling in verte-
brates. Metabolic enzymes, binding proteins, and nuclear receptors are shown in blue. Names in bold letters indicate the presence of a gene encoding the ortholog of a
given vertebrate protein in the P. dumerilii genome. Italic lettering indicates the absence of the complete corresponding gene family in P. dumerilii. Names in regular
letters indicate the presence, in P. dumerilii, of members of a given gene family but the absence of a specific P. dumerilii ortholog of the corresponding vertebrate
gene. Of note, the involvement of ADH enzymes in retinal synthesis in vertebrates has been challenged (3).2 of 16









pathway are conserved between P. dumerilii and vertebrates (that is,
ligand production/degradation and receptors), key mechanisms for ret-
inoid storage, intercellular transport, cellular uptake, and intracellular
binding of retinoids are not. This is consistent with the idea that the
vertebrate components for hepatic storage, mobilization, and transport
of retinoids were lineage-specific innovations (18).
Molecular characterization of the PduRAR
To characterize the PduRAR and PduRXR proteins in vitro, we cloned
and expressed the respective genes. The DNA binding domain of the
annelid RAR shares approximately 88% sequence identity with that
of the three humanRARs (RARa, RARb, andRARg) and 92%with that
of a recently identified mollusk RAR (N. lapillus) (16). In contrast, the
LBD shares only about 55% identity with that of the human RARs and
60% with that of the N. lapillus RAR, and of the 25 amino acids known
to interact with ATRA in the LBP of the human RARa (19), 5 are dif-
ferent in the annelid ortholog (fig. S2).
The DNA binding properties of the annelid RAR/RXR heterodimer
were validated using electrophoretic mobility shift assays (EMSAs)
(Fig. 2A). Binding was assessed on consensus direct repeat (DR)
elements as defined for vertebrates (8). Using a radiolabeledDR2 probe,
no binding of RAR or RXR alone could be detected. In contrast, the
RAR/RXR heterodimer strongly bound the DR2 element. This binding
was specific because it was outcompeted by an excess of unlabeled DR2
probe but not by a nonspecific unlabeled probe. Binding was also lost in
the presence of unlabeled DR1 and DR5. Other elements, such as DR0,
DR3, and DR4, induced only marginal competition. These results indi-
cate that the annelidRAR/RXRheterodimer binds specifically to a range
of RAREs very similar to those of its vertebrate orthologs (that is, DR1,
DR2, and DR5).
We subsequently tested the ability of the PduRAR to bind different
retinoids and activate transcription in a ligand-dependent manner.
First, we performed transient transactivation assays using a Gal4
LBD receptor chimera. Our results show that the RAR LBD is able to
activate transcription of a luciferase reporter gene in a dose-dependent
manner in the presence of ATRA, 13cRA, and 9cRA, with ATRA and
13cRA eliciting a stronger response than 9cRA (Fig. 2B). However, it is
important to note that for any of the three ligands, an activation of the
receptor was observed only with relatively high ligand concentrations
(1 to 10 mM). This is in stark contrast to the situation in vertebrates,
where RAR activation by ATRA is already observed at a concentration
of 1 nM (20).
Direct binding analyses of PduRAR to different ligands using
limited proteolysis assays (LPAs) confirmed these results (Fig. 2C). We
observed that, starting at a concentration of 1 mM, the RAR LBD was
protected from proteolysis by all three ligands. The specificity of these
effects was validated using the RAR antagonist BMS493 (21). In the pres-
ence of ATRA, high concentrations of BMS493 (10 mM) induced a de-
crease in the transcription of the luciferase reporter gene (Fig. 2D).
Furthermore, LPAs showed a BMS493-induced protection from proteol-
ysis starting at a concentration of 1 mM, indicating that BMS493 binding
to the LBD antagonized the ATRA-dependent transcriptional activity of
RAR (Fig. 2E). Of note, the annelid RXR activated transcription of a lu-
ciferase reporter gene in a concentration-dependent manner using either
9cRA or the RXR-specific agonist BMS649 (fig. S3A) (22). Moreover, the
use of the RXR-specific antagonist UVI3003 (23) inhibited RXR tran-
scriptional activity (fig. S3B).
After the characterization of the ligand-binding properties, we as-
sessed the capacity of the annelidRAR to interactwith receptor cofactors,Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018Fig. 2. Molecular characterization of PduRAR. (A) DNA recognition by the PduRAR/
PduRXR heterodimer. Both receptors were synthesized in vitro, and the heterodimer was
allowed to bind to a 32P-labeled DR2 RARE probe. Cold competitors correspond to 10- or
100-fold excess of unlabeled oligonucleotides (DR0 to DR5). A nonspecific element (NS)
was used as a negative control. Unprogrammed reticulocytes were used as control (Ctrl).
Protein and labeledprobe complexes are indicatedbyan arrow (shownonly in thePduRAR/
PduRXR lane). (B) TheabilityofPduRARtoactivate the transcriptionof the luciferase reporter
genewas tested in transfectedhumanembryonic kidney (HEK) 293Tcells in thepresence
of increasing concentrations (0.1, 1, and 10 mM) of ATRA, 9cRA, and 13cRA. TheGal4DNA
bindingdomain construct alonewas used as a negative control (Ctrl). Bars aremeans ± SD
(n = 3). (C) The ability of PduRAR to bind different ligands was tested by LPA. The ligands
(ATRA, 9cRA, and 13cRA) were used at increasing concentrations (0.1, 1, and 10 mM).
Ethanol was used as a negative control (lane −), and protected bands are indicated by
arrows. (D) Competition assay using increasing concentrations of the RAR antagonist
BMS493 (0.1, 1, and 10 mM) in the presence of 10 mM ATRA. The Gal4 DNA binding
domain construct alone was used as a negative control (Ctrl). Bars are means ± SD
(n = 3). (E) Binding of PduRAR to increasing concentrations of BMS493 (0.1, 1, and
10 mM) as assessed by LPA. Ethanol was used as a negative control (lane −), and
protected bands are indicated by arrows. (F) Titration of the fluorescein-labeled interac-
tion domains (ID1 and ID2) of the corepressors NCOR (nuclear receptor corepressor) and
SMRT (silencing mediator for retinoid and thyroid hormone receptors) by unliganded
PduRAR monitored by fluorescence anisotropy. Assays were performed in three
independent experiments, and data are expressed as means ± SEM. (G) Titration of
the fluorescein-labeled interaction domain 1 (ID1) of the corepressor NCOR by PduRAR
in the presence of different retinoids: ATRA, 9cRA, and 13cRA. Assays were performed in
three independent experiments, and data are expressed as means ± SEM.3 of 16
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nloadedusing a fluorescence-based assay that monitors the ligand-induced as-
sociation of cofactor fragments. Two corepressors, NCOR (nuclear re-
ceptor corepressor) and SMRT (silencing mediator for retinoid and
thyroid hormone receptor), were analyzed because they are known to
interact with unliganded vertebrate receptors through two interaction
domains (called ID1 and ID2) (24). Using fluorescein-labeled peptides
derived fromNCOR and SMRT, we first evaluated the binding prefer-
ences of RAR in the absence of ligand. We found that RAR bound
most avidly to NCOR ID1 (Fig. 2F). We then titrated the NCOR ID1
peptide with RAR in the presence of different retinoids (ATRA, 13cRA,
and 9cRA) (Fig. 2G). As expected, we observed that the three retinoids
are able to bind to RAR and induce NCOR ID1 release, with ATRA
being more potent than 13cRA and 9cRA in inducing the dissociation
(Fig. 2G).
To gain insights into themolecular mechanisms of annelid RAR lig-
and binding, we determined the crystal structure of the LBD of the
PduRAR in complex with ATRA at a resolution of 2.7 Å (table S1).
The asymmetric unit contained four molecules organized as two LBD
homodimers (fig. S4A). Electron density for the ligand was only visible
in subunits B and D, each of which formed dimers with a nonliganded
LBD (subunits A and C, respectively) (fig. S4, A and B). All four sub-
units superimposed very well, except in the N-terminal region of helixHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018H3 and theC-terminal part of the domain containing helixH11 and the
activation helix H12 (Fig. 3A). In molecules B and D, the N termini of
helix H3 and helix H11 were shifted outward of the LBP to accommo-
date the ATRA molecule. Unexpectedly, helices H12 of the ligand-
bound molecules B and D were not stabilized in the so-called
agonist-bound or active conformation but docked onto the surface of
a symmetry-related liganded LBD, resulting in an arm-exchanged con-
formation (Fig. 3A and fig. S4C). We were unable to observe any inter-
pretable electron density for the ligand in molecules A and C, whose
helices H12 were in the agonist- and antagonist-bound conformations,
respectively (Fig. 3A). Both subunits B and D bound ATRA in an ori-
entation that has never been observed in mammalian RAR structures
(Fig. 3B). Althoughmolecules B andDwere involved in different crystal
packing interactions, their ATRAmolecules were fully superimposable,
strongly supporting the fact that the unusual bindingmode of the ligand
was not influenced by crystal packing constraints.
In human RARa, the LBP extends fromhelix H11 on one side to the
two conserved polar residues R276 in helixH5 and S287 in the tip of the
b-turn S1/S2, which form a hydrogen bond network with the carboxyl-
atemoiety of the retinoid ligand on the other side (Fig. 3B). In contrast,
in the PduRAR, the ligand is rotated by almost 90°, resulting in the






Fig. 3. Crystal structure of the PduRAR LBD. (A) Superimposition of the four PduRAR LBDs (Mol A to Mol D) contained in the asymmetric unit. a Helices (H1 to H12)
are labeled. The two ATRA molecules present in subunits B and D are shown as yellow sticks. (B) Superimposition of the LBPs of human RARa bound to the agonist
AM580 (yellow) and of the PduRAR (Mol B) bound to ATRA (blue). The ATRA present in Mol D (which was superimposed on Mol B and is not shown) is displayed as
green sticks. Human RARa R276 and S287 that are engaged in polar interactions with the carboxylate moiety of AM580 are shown. (C) Close-up view of the LBP of
PduRAR bound to ATRA. Residues in contact with the ligand are shown and labeled. (D) Superimposition of the LBPs of human RARa bound to the agonist AM580
(yellow) and of the PduRAR (Mol B) bound to ATRA (blue) showing how the V356F mutation affects ligand binding to the annelid receptor. (E) Transcriptional activity of
the PduRAR V356F mutant, in transfected HEK 293T cells, in the presence of increasing concentrations of ATRA (1, 5, and 10 mM). The GAL4 DNA binding domain alone
was used as a negative control (Ctrl). Bars are means ± SD (n = 3). (F) Superimposition of the LBPs of human RARa bound to the agonist AM580 (yellow) and of the
PduRAR (Mol B) bound to ATRA (blue). The van der Waals interactions between AM580 and helix H12 residues I410 and L414 are indicated as dotted lines. (G) Su-
perimposition of the LBPs of human RARa bound to the agonist AM580 (yellow) and of the PduRAR (Mol B) bound to ATRA (blue), highlighting the smaller distances
between equivalent residue positions in helices H3 and H11 in the annelid receptor when compared to vertebrate receptors.4 of 16









H3 andH6 (Fig. 3, A and B). The vast majority of the contacts made by
ATRA with the LBP were loose van der Waals interactions, and the
carboxylate moiety of the ligand did not form any noticeable hydro-
gen bonds with surrounding LBP residues (Fig. 3C). This structure
suggested that the carboxylate moiety plays little role in the binding
of retinoids to PduRAR, which strongly contrasts the situation in hu-
man RARs. This observation was in agreement with our cell-based
results showing similar binding efficiencies of ATRA, 13cRA, and
9cRA for the annelid receptor (Fig. 2B). To validate the alternative
binding mode of PduRAR, we mutated the valine at position 356 in
helix H3 into a phenylalanine (V356F), which is the corresponding
residue at this position in human RARs (F228 in RARa) (Fig. 3D).
On the basis of the structure, this substitution should specifically affect
the PduRAR bindingmode. In agreement with this hypothesis, we ob-
served a marked decrease in the capacity of ATRA to activate the
V356F mutant (Fig. 3E).
Comparisons of the ATRA-bound PduRAR LBD structure to that
of the human RARa LBD bound to the agonist AM580 (24) revealed
another striking difference with possible functional implications.
When superimposing the two structures, we observed that, in the hu-
man receptor, AM580 inserts its tetramethyl-cyclohexyl ring between
helices H3 and H11, whereas in the annelid RAR, the b-ionone ring of
ATRA resided deeper within the LBP (Fig. 3F). As a consequence,
helices H3 and H11 are closer to each other in the liganded PduRAR,
hence generating a possibly suboptimal docking surface for helix H12
in the transcriptionally active conformation (Fig. 3, F and G). More-
over, although direct contacts exist between agonist ligands and helix
H12 residues (I410 and L414) in human RARa, no such interactions
were observed in the ATRA-boundPduRAR (Fig. 3F). These observed
structural differences between the annelid and humanRARLBDs sug-
gested that ATRA only weakly stabilizes the active conformation of
helixH12 in the PduRAR. This finding explained both the dissociation
of helix H12 from its LBD core in the B and D subunit structures and
the significantly weaker ATRA-induced transcriptional activity of the
annelid receptor in cell-based assays, when compared to the activity of
a typical human RAR (fig. S4D).
Together, our functional and structural data indicate that PduRAR
is able to bind different RA isomers (at least ATRA, 13cRA, and 9cRA)
with a micromolar affinity by using distinctive ligand-binding
modes and structural responses when compared to vertebrate RARs.Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018Thus, PduRAR likely behaves as a sensor rather than as a high-affinity
receptor.
Retinoids in developing and adult P. dumerilii
To test whether RA is present in P. dumerilii, we next determined the
retinoid contents in eggs, embryos, larvae, and adults using liquid chro-
matography–tandemmass spectrometry (LC-MS/MS) for RA (4, 25)
and high-performance liquid chromatography with ultraviolet detection
(HPLC-UV) for retinol and retinyl esters (4). We were able to identify
ATRA, 13cRA, retinol, and retinyl esters but failed to detect 9cRA above
the limit of detection of our assay (Table 1) (25). The concentrations of
ATRA and 13cRA were in the same range, and often, 13cRA was pre-
sent at higher levels than ATRA (Table 1). For example, in P. dumerilii
adults, we detected 38.3 ± 4.03 pmol/g tissue of ATRA and 46.8 ± 3.89
pmol/g tissue of 13cRA (Table 1), with one unit of pmol/g tissue of a
given retinoid translating, approximately, into an average concentration
of 1 nM (26). This finding contrasts with the situation in vertebrates,
whereATRA levels generally tend to be higher than those of 13cRA (26).
Retinoidswere further quantified in unfertilized eggs and at different
developmental stages: 18 hours post-fertilization (hpf) (gastrulating
protrochophore), 51 hpf (early metatrochophore larva), and 74 hpf
(early nectochaete larva) (17). The relative levels of ATRA and 13cRA
were generally lower during embryogenesis than in the adult, in accord-
ancewith the notion that embryonic retinoids are synthesized frompre-
cursor molecules stored in the egg, whereas, in adults, precursors are
obtained from the diet. During embryogenesis, ATRA levels were
highest during gastrulation (4.58 ± 0.16 pmol/g tissue), whereas 13cRA
levels were highest in 51 hpf larvae (7.47 ± 4.63 pmol/g tissue) and gas-
trulating embryos (6.34 ± 2.21 pmol/g tissue) (Table 1). These results sug-
gest that, as in vertebrates, active retinoid levels are tightly controlled,
although the kinetics of ATRA and 13cRA levels during P. dumerilii
embryogenesis differ, suggesting distinct control mechanisms. Further-
more, given thatATRAand 13cRA levels were assessed inwhole animals,
we expect that RA concentrations are significantly higher in target tissues,
hence leading to the ligand-dependent activation of PduRAR.
Retinol and retinyl esters serve as precursors for the synthesis of RA
in vertebrates (3, 27). In P. dumerilii, we observedmuch higher levels of
retinol and retinyl esters than of ATRA or 13cRA (Table 1), similar to
what is observed in vertebrates (3, 4, 26), which suggests that these
retinoids also serve as precursors for RA synthesis in the annelid. TheTable 1. Endogenous retinoids in P. dumerilii. Values are means ± SD. Serum values are pmol/g tissue. n.d., not detected. Developmental stages correspond
to gastrulation at 18 hpf, the early metatrochophore larva at 51 hpf, and the early nectochaete larva at 74 hpf.Stage ATRA 9cRA 13cRA8
Retinol2
Retinyl estersUnfertilized egg
(n = 4)0.92 ± 0.74 n.d. 0.73 ± 0.41 50 ± 31.25 180 ± 68.66Gastrulating protrochophore
(n = 2)4.58 ± 0.16 n.d. 6.34 ± 2.21 420 ± 200 1000 ± 417.81Early metatrochophore larva
(n = 9)2.74 ± 1.52 n.d. 7.47 ± 4.63 830 ± 489.34 1880 ± 1004.92Early nectochaete larva
(n = 6)3.39 ± 1.10 n.d. 2.53 ± 1.17 300 ± 125.65 900 ± 567.46Adult worm
(n = 4)38.3 ± 4.03 n.d. 46.8 ± 3.89 78.5 ± 102.3 2170 ± 45815 of 16









fact that retinol and retinyl ester levels are higher in gastrulating
embryos than in eggs suggests that retinoids are stored in other forms
in the oocyte and that, when embryonic transcription starts, retinol and
retinyl esters are synthesized from these alternatively stored retinoids.
Expression of genes involved in RA synthesis, signaling,
and degradation
The biosynthesis of RA is best tracked by studying genes involved in its
metabolism. In vertebrates, RALDH enzymes are enriched in somatic
tissues at the interface between the yolk sac and the embryo (28). In
P. dumerilii, three of five aldh1a paralogs (aldh1a_1, aldh1a_4, and
aldh1a_5), which are likely involved in RA synthesis, were found in the
yolky macromeres (fig. S5, A, B, C, E, F, H, and J to M) and in the ad-
jacent mesodermal bands that stretch out between themacromeres and
the overlying neuroectoderm (fig. S5, F andG). This expression is in line
with the notion that RAmetabolism takes place in the annelid yolk and
that oxidation to RA is performed either in the yolk itself or in the
overlying early-forming somites. Once the midgut is formed, the three
aldh1a geneswere expressed in tissues surrounding themidgut, suggest-
ing a function related to food intake and the control of metabolism
(fig. S5, D, I, and N). A fourth aldh1a gene, aldh1a_3, was expressed in
other tissues (fig. S5, O to R). The in situ hybridization experiments
targeting the fifth P. dumerilii aldh1a paralog, aldh1a_2, did not yield
any results, which is likely due to low developmental expression levels.
The three P. dumerilii cyp26 genes (cyp26_1, cyp26_2, and cyp26_3)
showed expression in the midgut, which is consistent with a possible
modulation of RA activity in this tissue (fig. S5, S to U).
To determine where the RA signal is received, we analyzed the ex-
pression of the annelid RAR and RXR. The first prominent expression
of the rar gene was in the larval neuroectoderm (Fig. 4, A to C), and at
48 hpf it was spatially restricted to the medial domain (Fig. 4C), where
pax6 and nk6 expression overlap and hb9+motor neurons differenti-
ate (29). Lateral neuroectodermwas devoid of expression. At the same
time, rar was also expressed in the brain (Fig. 4, A to D) and in the
developing mesodermal bands in the trunk (Fig. 4, A to C). Starting be-
tween 24 and 30 hpf, the rar gene was further detectable in the developing
stomodeum and proctodeum, where it remained expressed until 72 hpf
(Fig. 4, B to D). Furthermore, in the young worm, rar was expressed in
the midgut (Fig. 4E). Coherent with a possible dimerization of RAR
and RXR, the rxr gene was expressed at similar stages in the same tissues
(neuroectoderm, brain,mesoderm, stomodeum, andmidgut) (Fig. 4, F to
I). Together, the expression patterns of the main RA signaling compo-
nents in P. dumerilii (Fig. 4, J to M) are consistent with the notion that
endogenously producedRAactivates RAR/RXRheterodimers in a tissue-
specific manner to function during development of the nervous system
and the alimentary canal.
Medial neuron differentiation and connective formation
defects in RAR and RXR knockdowns
The overlapping neuroectodermal expression of rar and rxr genes in
conjunction with the ability of both receptors to form heterodimers
suggests a functional interaction in vivo to control nervous system de-
velopment. To test this hypothesis, we targeted rar and rxr translation
by amorpholino oligonucleotide (MO) knockdown approach. As a first
test for the capacity and specificity of the synthesized MOs to inhibit
translation in P. dumerilii, we injected, into one-cell– to two-cell–stage
embryos, h2b-gfp mRNA with an upstream MO target sequence
together with the rar MO, rxr MO, or 5-mismatch control MOs. We
found that both the rar and rxrMOs specifically abolished green fluo-Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018rescent protein (GFP) expression of their respective mRNAs (fig. S6)
and noted a general developmental delay for all MO injections (Fig. 5),
which is consistent with previous reports on the use of MOs in devel-
opmental systems (30).
Larvae injected with rar MO developed regularly into larval stages
(98%, n = 363), comparable to controls (98%, n = 196). To score for
morphological effects, we labeled fixed larvae with 4′,6-diamidino-2-
phenylindole (DAPI) and with an antibody directed against acetylated
tubulin that labels axons and cilia (29, 31). Morphological defects
became apparent in the fully developed metatrochophore larva, with
aberrant axonal scaffolds in the differentiating ventral nerve cord that
were clearly distinct from control MO-injected scaffolds (Fig. 5, A, C,
E, and I). The rar morphants exhibited overall reduced connectives
(50%, n = 22), whereas commissural axons appeared less affected (Fig.
5, C and E). Although commissural trajectories were partially
disorganized, the capacity of axons to cross themidline was not impaired
(Fig. 5,C andE).Wealso analyzed larvae injectedwith rxrMOand found
them to be overall morphologically very similar to the rarMO–injected
ones, characterized by a specific reduction of connectives and altered
commissural bundling (75%, n = 60) (Fig. 5, G and I). In addition, we
observed a behavioral effect in rxr MO–injected larvae in that some
did not swim but rather stayed on the bottom of the dish, although they
were agile and appeared normally developed (55%, n = 286).
Analysis of synaptotagmin expression, a marker for presynaptic dif-
ferentiation, in rarmorphants revealed a specific decrease of neurons in
themedial trunk domain that differentiates between 22 and 56 hpf (29),
whereas earlier forming larval neurons were unaffected (100%, n = 4)
(Fig. 5, L andM). This suggests a specific requirement for RA signaling
in larval neuronal differentiation in the medial neuroectoderm. To
corroborate this point, because serotonin is an abundant neuro-
transmitter in both the larval nervous system and the ventral nerve cord
(29), we investigated the development of serotonergic neurons in
P. dumerilii rar and rxrmorphants. We found that, after both rar and
rxr MO injections, the early developing, embryonic serotonergic neu-
rons were unaffected, whereas the number of the later differentiating,
larval serotonergic neurons was reduced (Fig. 5, B, D, F, H, J, and K).
This reduction was more pronounced in terminally differentiated
serotonergic neurons (with axons) (Fig. 5K) than in differentiating
serotonin-positive cells (without axons) (Fig. 5J).
We next assessed the expression of the transcription factor hb9,
which specificallymarksmotor neurons differentiating from themedial
neuroectoderm in both annelids (29) and vertebrates (32). InP. dumerilii
larvae injected with rar MO, we found reduced hb9-expressing cells
(55%, n = 9) (Fig. 5, N and O). Finally, we tested whether the failure
to differentiate medial nerve cord neurons is due to disturbed larval
patterning mediated by hox genes, which, in P. dumerilii, show spatial
colinear expression along the trunk neuroectoderm (33). Contradicting
this notion, the segmental expression of hox1 in the neuroectoderm was
not affected by rar MO injections (100%, n = 20) (Fig. 5, P and Q).
In line with rar and rxr expression in the stomodeum, which later
develops into the larval foregut, we further observed a duplication (18%,
n = 22) or enlargement (27%, n = 22) of the stomodeum after rarMO
injections (Fig. 5, A, C, E, and I), indicating that the reception of an en-
dogenous RA signal is also required for proper stomodeal development.
Comparable stomodeum duplications (8%, n = 60) or enlargements
(16%, n = 60) were also observed in rxr knockdown specimens (Fig. 5,
G and I).
Finally, coinjection of the rar and rxrMOs (at lower concentrations)
resulted in phenotypes identical to those obtained by single MO6 of 16









injections in both ventral nerve cord and stomodeum (Fig. 5I), indicat-
ing that RAR and RXR cooperatively function in the same signaling
cascade as RAR/RXR heterodimers mediating RA signaling during
P. dumerilii development.
Enhanced commissural axon formation induced by ectopic
RAR activity
To complement theMO-based knockdown results, we injectedmRNAs
encoding the full-length RAR protein into P. dumerilii zygotes. Ectopic
expression of rar led to alterations of axonal scaffolds at the end of the
larval differentiation phase (Fig. 5, T to V), in line with the phenotypes
of rarMO–injected larvae. In rarmRNA–injected larvae fixed at 48 hpf,
we observed an increase in the formation of commissural axons,
whereas the formation of longitudinal connectives appeared unaffected
(Fig. 5, T and U). The ectopic commissural axons most likely emerge
from themore lateral neuroectodermal regions (29), where commissur-
al neurons are located in wild-type larvae. Notably, rarmRNA–injected
larvae fixed at early larval stages (at 41 hpf) did not show a phenotype inHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018the ventral nerve cord, which is consistent with the notion that, during
neurogenesis, endogenous RAR-dependent signaling is required at lar-
val rather than prelarval stages (Fig. 5, R, S, andV). Together, the results
of the rar overexpression and knockdown experiments are consistent
with a role for RAR in neuronal differentiation and axon formation
within the medial part of the larval P. dumerilii neuroectoderm.
Impaired medial neuron differentiation by neuroblast
depletion following ATRA and 13cRA treatments
To further investigate the roles of RA signaling in larval ventral nerve
cord development, we assessed the effects of exogenous ATRA and
13cRA, the two active RA isomers present during P. dumerilii develop-
ment. Larvae were treated with increasing concentrations of both
compounds in the micromolar range. Both ATRA and 13cRA treat-
ments at larval stages slowed down the locomotion of the larvae and
completely abolished crawling movements (movie S1), which is indic-
ative of a specific effect on the differentiation and possibly projection of
motor neurons innervating the somatic musculature. For comparison,Fig. 4. Expression of retinoid receptors (rar and rxr) in P. dumerilii. Gene expression is shown in blue. (A to E) P. dumerilii rar expression. (A to C) rar expression in
forming neuroectoderm (ne), mesodermal precursor cells [dorsal longitudinal muscle (dlm) and mesodermal bands (mdb)], posterior growth zone (black arrowheads),
and the brain region (br). (C) At 48 hpf, rar is expressed in neuroectoderm, in a region giving rise to motor neurons (yellow dashed circles), in the ventral midline (arrow,
left) and subjacent cells (white arrowhead, right). (B to D) Stomodeal rar expression at 30 to 72 hpf (circles). (D) rar is expressed in two dorsally located domains of the
brain at 72 hpf (white arrowheads). (E) At 6 dpf (days post-fertilization), rar is expressed in the midgut (mg) and posterior growth zone (black arrowhead). (F to I)
P. dumerilii rxr expression. (F) At 24 hpf, rxr is expressed in the ventral midline (arrow) and two domains of the brain (black arrowheads). (G and H) In trochophore and
nectochaete larvae, rxr is expressed in the brain (br) and the entire neuroectoderm (ne), including motor neuron domains (yellow dashed outline), and in the underlying
mesodermal precursor cells (mdb) and stomodeum (circle). (I) By 5 dpf, rxr expression is restricted to two domains of the brain (arrowheads) and to tissues surrounding the
midgut (mg). (J to M) Summary of the developmental expression in P. dumerilii of RA metabolism and signaling components. At 24 hpf (J), 48 hpf (K), and 72 hpf (L), aldh1a
(green) genes are expressed in the blastoporal region and macromeres, whereas rar (purple) is in neuroectoderm and stomodeum. aldh1a and rar expression overlap in the
forming mesodermal bands. (M) In the late nectochaete larva (5 to 6 dpf), aldh1a, cyp26, and rar expression overlap in the midgut (red). Ventral views of larvae are shown. Scale
bars, 50 mm. * or circle, foregut; white dashed line, ciliated band; yellow dashed circles, motor neuron domain.7 of 16









similar treatments did not slow down the swimming speed of prelarvae
(movie S2).
Concerning axonal scaffold formation, treatments with both com-
pounds from 48 to 80 hpf led to a clear concentration-dependent reduc-
tion in length and density of longitudinal connectives, with the overall
number of commissural projections being less affected (Fig. 6, A to E
and P). Of note, 13cRA treatments resulted in more severe phenotypes
than ATRA treatments at the same concentration. Corroborating this
further, treated larvae generally showed a reduction of differentiatedHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018serotonergic neurons that are longitudinally projecting, an effect, again,
more pronounced for 13cRA than for ATRA treatments (Fig. 6, F to J
andQ). ATRA and 13cRA further decreased the number of hb9-positive
cells in the neuroectoderm but not in the stomodeum (fig. S7, A to F). In
contrast, the anterior spatial boundary of the neuroectodermal expres-
sionofhox1 andhox4wasunaffected (fig. S7,G to I andMtoO),whereas
that of hox1 at the base of the cirri and in the stomodeum was down-
regulated (fig. S7, J to L). Therefore, and strikingly, rar MO–injected
and RA-treated larvae showed very similar phenotypes.Fig. 5. Perturbation of RAR and RXR functions in P. dumerilii. (A to Q) Knockdown of rar and rxr by MO injections into P. dumerilii zygotes. (A, C, E, and G) rar and rxr
MO injections cause a reduction of connectives (conn; white arrows) and misguidance of commissures (comm; yellow arrows) in the ventral nerve cord (VNC) as well as
stomodeal defects including duplications (white dashed circle). (B, D, F, and H) Misplacement and reduction of larval serotonergic neurons (arrows), but not of neurons
of the early nervous system (arrowheads), upon rar and rxr MO injections. (I) Histogram showing proportions of obtained knockdown phenotypes: normal development
(“normal”), delayed development (“delay”), and VNC and stomodeum defects (“VNC & stomodeum defects”). (J and K) Box plots showing the number of serotonergic
cells and neurons in the trunk of P. dumerilii larvae. Data distribution (circles), median values (bold line), and Tukey whiskers are shown. wt, wild type. Unpaired t test on
the mean value was used for statistical analyses (n.s., nonsignificant). P = 0.3352 and P = 0.5842 in (J) and P = 0.0566 and P = 0.6064 in (K) for, respectively, rxr-5mm
control MO versus rar MO and rxr-5mm control MO versus rxr MO. (L to O) Expression of the neuronal differentiation marker synaptotagmin (syt) (L and M) and of the
motor neuron marker hb9 (N and O), showing that MO-induced rar knockdown disrupts differentiation in the larval nervous system (arrows), but not in the early larval
nervous system (arrowheads). (P and Q) hox1 expression is unaffected by rar MO injections (arrowheads). (R to U) rar overexpression by mRNA injection into P. dumerilii
zygotes. (R and S) Early larval nervous system is not affected by rar overexpression (arrows). (T and U) Injection of rar mRNA induces an increase of commissures in the
larval nervous system (arrows). (V) Overview of embryonic and larval neurogenesis in P. dumerilii with respect to the differentiation (diff.) of functional neurons (29).
Ventral views of larvae are shown. (A to H and R to U) Acetylated tubulin in green, serotonin in red, and nuclei in blue. (L to Q) Gene expression in blue. Number of
affected over total number of assayed specimens is indicated. Scale bars, 50 mm.8 of 16
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nloadCounterintuitive at first, we reasoned that if RA acted as a motor
neuron differentiation signal, it might interfere with the maintenance
of asymmetrically dividing neuroblast stem cells in the neuroectoderm.
Consistent with this notion, we noted a marked reduction of cell divi-
sion in the neuroectodermal tissue in both ATRA- and 13cRA-treated
larvae after 4 hours of 5-ethynyl-2′-deoxyuridine (EdU) incubation,
whereas cell proliferation in the brain appeared largely unaffected
(Fig. 6, K to O). Tomore specifically test for the presence of neuroblasts
in treated young worms, we assessed neuroectodermal nk6 and pax6
expression at early larval stages, which demarcates both proliferating
stem cell–like neuroectodermal precursors and differentiating neurons
(29). In line with the above observations, the expression of both markers
was strongly reduced in a concentration-dependent manner after treat-
ments at early larval stages (Fig. 6, R to T and V to X). Optical cross-
sections revealed that the expression of both genes was reduced in deep
tissue layers, where differentiating neurons are located and completely
abolished in superficial layers containing dividing neuroblasts (Fig. 6, U
and Y). Therefore, the reduced number of differentiating motor neurons
appears to be paralleled by a depletion of neuroblasts giving rise to these
neurons, which suggests that the effect of RA treatment is on the dividing






We have exhaustively characterized RA signaling, both biochemically
and functionally, in the developing marine annelid P. dumerilii. Our
work establishes firmly that RAR-mediated RA signaling evolved in
early bilaterians. However, our data also suggest an early role of this
pathway very different from the control of hox anteroposterior patterning
that has been described for vertebrates.
First, the affinity of the PduRAR for its ligands (ATRA or 13cRA)
and its level of activation by these ligands are much lower than those
known for vertebrate receptors. For the annelid receptor, micromolar
retinoid doses were necessary to reach 1/10 of the transcriptional activity
measured for human RARa at nanomolar retinoid concentrations (8).
Our structural analyses established that PduRAR accommodates ATRA
via a binding mode that is different from the one used by vertebrate
RARs. In the P. dumerilii orientation, the ligand does not generate
the necessary contacts with residues of the RAR LBP to ensure high-
affinity binding and strong stabilization of the transcriptionally active
receptor conformation. Given that endogenous retinoid levels do not
seem to be overtly elevated in both developing and adult worms,
when compared to those in vertebrates (3, 4, 26), the annelid RAR
thus appears to act as a retinoid sensor rather than as a vertebrate-type
high-affinity receptor. Such a sensor role is exerted in tissues that are
characterized by high exposure to RA, such as the neuroectoderm
overlying theRAproducingmesodermal bands andmidgut. It is further
supported by the fact that PduRAR is activated by ATRA and 13cRA,
which are present in equivalent amounts in embryos and adults. In line
with our data, the RAR of the sea urchin, a deuterostome, is character-
ized by a ligand affinity comparable to that of PduRAR (34). Together,
these results indicate that the ancestral RAR, which evolved at the base
of the bilaterians, might have been a retinoid sensor and that high-
affinity RARs probably evolved only later, specifically in the chordate
lineage.
Second, the affinity refinement of chordate RARs was very likely
correlated with other modifications of the RA pathway. For example,
our study revealed that annelids differ from chordates in the com-
plements of retinoid binding and transport proteins (that is, STRA6,Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018RBP4, TTR, CRBP, and CRABP), all of which are absent from annelids.
This suggests that the ancient mode of signal propagation was by mere
diffusion (both extra- and intracellularly) or that retinoid binding and
transport have primitively been assumed by other factors and that this
primitive system has secondarily been replaced in chordates. An intra-
cellular retinoid binding capacity, for example, has already been de-
scribed for members of the ILBP (intracellular lipid binding protein)
superfamily in other protostomes, such as insects and crustaceans
(35, 36).
Third, another pivotal difference between the annelid and chordate
RA systems is the absence of an axial patterning function in annelids,
together with the lack of a direct regulation of hox genes. This classical
andwell-known developmental function of RA signaling has so far only
been demonstrated in chordates, although it still remains to be ad-
dressed in echinoderms and hemichordates. Therefore, this role of
RA can be considered either a deuterostome or chordate synapomorphy,
and it may have evolved concomitantly with the elaboration of high-
affinity RARs. The echeloned response of different hox genes to RA
would thus be the consequence of a gain of regulatory precision by a
high-affinity receptor that is capable of interpreting minute ligand con-
centration differences along an anteroposteriormorphogen gradient. In
chordates, this gradient provides positional information along the
anteroposterior body axis to specify the location and fates of particular
structures in all germ layers (2). In zebrafish, for example, it has been
shown that RA can directly convey tiered positional information over
long distances, functioning in a gradient that is robust to fluctuations of
RA synthesis and whose establishment requires CYP26-dependent RA
degradation (37). Together, we propose that the transformation of RAR
from a sensor to a high-affinity receptor, which likely took place at the
base of the chordates, was a prerequisite for the acquisition of a global
axial patterning function of RA as a gradient-forming morphogen.
On the basis of these findings and additional comparative studies, a
coherent view of RA signaling evolution is emerging. Early inmetazoan
evolution, retinoids appear to have been recruited as signaling mole-
cules. Although RAR itself is absent in cnidarians, the existence of
RXRorthologs activatedby 9cRA indicates the existence of nuclear recep-
tors capable of mediating retinoid actions (38), possibly as homodimers
or heterodimers with other nuclear receptors (39). In cnidarians, two
major roles have emerged that may be derived from ancient RA
signaling functions. First, RA controls the strobilation process in the
jellyfish Aurelia aurita, that is, the metamorphosis from the polyp to
the medusa stage (39). During this process, RA appears to be produced
by the inner layer because the expression of raldh is strongest in the
endoderm of the mouth region, where strobilation is initiated. In con-
trast, rxr is present in the overlying ectoderm. Second, RA signaling
appears to play an ancient role in neuronal differentiation. An RXR an-
tibody labels different types of neurons in the polyps of the sea pansy
Renilla koellikeri and the coral Acropora millepora (40), suggesting a
role in neurogenesis. In line with this hypothesis, RA induces neuronal
differentiation inR. koellikeri primary cell cultures (41), and RA-treated
planula larvae of the hydrozoanClavamulticornis showed defects in the
differentiation and positioning of peptidergic neurons and, interesting-
ly, a disorganized arrangement of nerve net axons, indicative of an RA
function in axonal pathfinding (42).
Twomajor novelties in RA signaling then occurred in the bilaterian
stem line. First, RXR was complemented by a second RAR, which
forms heterodimers with RXR (8). We propose that, via opportunistic
evolution, RAR evolved as an RA sensor by exploiting preexisting
retinoids. This involved changes in specificity, from 9cRA (as reported9 of 16









Fig. 6. Effects of exogenous RA on developing P. dumerilii. (A to Q) Effects of ATRA and 13cRA on larval development (48 to 80 hpf). (A to E) Reduction of differentiationwithin
the VNC (in green, acetylated tubulin), particularly in longitudinal connectives (conn; white arrows) and less in commissural projections (comm; yellow arrows), was observed with
increasing RA concentrations. (F to J) Treatments reduce the number of differentiating serotonergic neurons (in red, serotonin) along the VNC (arrows). (K to O) Number of proliferating
cells (in purple, 4-hour EdU incubation) in larval neuroectoderm (circles) is reduced by ATRA and 13cRA, whereas cell proliferation in the larval brain is less affected (dashed circles). (A, F,
andK) The first (I), second (II), and third (III) larval segments are indicated. (P andQ) Boxplots of VNC lengthandwidthandof serotonergic neuronnumbers in dimethyl sulfoxide (DMSO)
controls andafter treatmentswith 4mMATRAor 4mM13cRA.Datadistribution (circles),median values (bold line), and Tukeywhiskers are shown.Unpaired t test on themeanvaluewas
used for statistical analyses (**P<0.01). (P) Ratio of VNC length and total body length, as shown in (A), and comparison of VNCwidth in the first twobody segments, indicated aswidth I
and II in (A). Leftboxplot:P=0.4048 forDMSOversusATRAandP=0.0006 forDMSOversus13cRA.Rightboxplot:P=0.002andP=0.0001 (width I) andP=0.0017andP=0.0001 (width
II) for, respectively, DMSOversusATRAandDMSOversus 13cRA. (Q) Serotonergic neuronnumbers inDMSO-, ATRA-, and13cRA-treatedembryos. P=0.6504 forDMSOversusATRAand
P=0.0001 for DMSOversus 13cRA. (R toY) Treatments reducenk6 (R to T) and pax6 (V to X) expression in the VNCduring larval development (34 to 40 hpf). Gene expression in pink. (U
and Y) Orthogonal optical sections showing the absence of nk6 and pax6 fromproliferating neuroectoderm (superficial layer, white outline) and decrease of nk6 and pax6 expression in
the postmitotic layers below the neuroectoderm (middle and deep layers, purple and yellow outlines, respectively). Ventral views of developing P. dumerilii are shown. Number of
affected over total number of assayed specimens is indicated. Scale bars, 50 mm [except (U) and (Y), 20 mm].Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018 10 of 16
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nloadedfor cnidarians) to 13cRA and ATRA (as prevalent in bilaterians), which
thus likely enabled and triggered a diversification of the downstream
effectors of RA signaling. Second, and concomitant with RAR, another
key actor of the pathway (namely CYP26) evolved, mediating RA deg-
radation. Targeted RA catabolism evolved to allow spatially and tempo-
rally refined RA signaling activity by removing the active ligand from
exempt tissue.We therefore propose that the origin of RAR and CYP26
in bilaterians coincided with the appearance of specific biological roles
for RA and with the need for a precise spatiotemporal control of RA
availability.
But what was the effect of such refined signaling? Application of
ATRA to individual neurons isolated from the central nervous system
of the gastropod mollusk Lymnaea stagnalis causes neurite outgrowth
and growth cone turning (43), as it does in the vertebrate spinal cord, for
example, in the chick embryo (44) and the regenerating adult newt (45),
supporting the notion that axonal guidance is an ancient function. Un-
fortunately, these studies in gastropod mollusks left open the source of
the signal and the nature of the receptor and did not address a possible
role in neuronal patterning or differentiation. Our study now reveals
that, during P. dumerilii development, RA produced by the underlying
mesodermal bands and midgut triggers neuronal differentiation in the
overlying neuroectoderm. More specifically, we observe effects on dif-Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018ferentiating motor neurons in the trunk of three-segmented young
worms, coupled with disorganized patterns of outgrowing axons. These
results are consistent with a role of RA signaling in axonal pathfinding
of motor neurons and associated interneurons, and, in more general
terms, with the somatic musculature promoting its own innervation
frommotor neurons at various steps (neuroblast proliferation, differen-
tiation, and axonal outgrowth). A similar role in neuronal differentia-
tion has been reported for vertebrates (46), which is independent of the
famous early role of RA signaling in hox-mediated anteroposterior
patterning. For example, in zebrafish neckless mutants with a defect
in raldh2, the differentiation of branchiomotor neurons is disturbed,
involving also migration defects and a disorganized axonal scaffold
(28, 47). Transplantation experiments have shown that the RA signal
originates in the underlying developing somatic musculature, as ob-
served here for the annelid. This opens up the fascinating possibility
that the evolution of RAR has been linked initially to the evolution of
bilaterianmotor circuits, enabling the usage of retinoids as a developmen-
tal timing signal at multiple steps of specification and differentiation.
Such an initial role in the control of differentiation of motor and in-
terneurons may elegantly explain the recruitment of RA signaling for
anteroposterior patterning via hox gene regulation. One pivotal role






Fig. 7. A simplified phylogeny of metazoan animals illustrating major events of RA signaling evolution. The color used for each taxon highlights the RA binding
capacity of the RAR: light blue for low-affinity sensors and dark blue for high-affinity receptors. Red circles highlight hypothesized events of RAR evolution, and green boxes
highlight the likely concomitant appearance of the two main developmental roles of RA signaling: in neuronal differentiation at the base of bilaterians and in anteroposterior
(AP) regional patterning via hox gene regulation at the base of chordates. Red stars indicate secondary RAR loss. Deutero, deuterostomes; Proto, protostomes.11 of 16
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and this is a direct readout of high-affinity RA signaling (48). It is thus
conceivable that the role of RA signaling in hox regulation evolved as a
result of “opportunistic evolution”: Because RA signaling control of
general motor neuron differentiation was already in place, RA was also
recruited as a signal for the more specific spatial control of anteropos-
terior subtype specification that evolved progressively in fins and limbs,
and, in this context, took over the (refined) control of anteroposterior
hox gene expression. This way, and reflecting its overall and more an-
cient role in the coordination of developmental timing, RA signaling
would then have become a global regulator of hox gene expression in
deuterostomes—likely at the base of chordates—to control the elabora-










The objectives of the presented research were to understand the ances-
tral role of the RA signaling pathway, mediated by RAR. Using the
annelid worm P. dumerilii as model organism, we approached our
biological question by means of a combination of different in silico,
in vitro, and in vivo approaches to identify RA signaling pathway com-
ponents, assess the molecular properties and crystal structure of RAR,
establish in vivo retinoid contents, define the developmental expression
of the main RA signaling mediators, and characterize the functions of
both RA and RAR during development. The functional experiments
were analyzed by behavioral studies (recording of the swimming behav-
ior of the larvae) and by immunohistochemistry (protein localization)
and in situ hybridization (gene expression patterns) on fixed control
and experimental specimens of P. dumerilii embryos or larvae. The in-
vestigators carrying out these analyses were blinded to the identities of
the samples (that is, control versus experimental). Retention of micro-
injected embryos in the analysis was based on the pattern of early de-
velopment (correct initial cell divisions and fusion of the small lipid
droplets into four bigger lipid droplets). Deviation from this early de-
velopmental pattern is a sign of traumatization and thus of damage to
the embryo caused by themicroinjection procedure (17). Biological and
technical replicas are indicated for each experiment.
Sequence alignments and phylogenetic analyses
Sequences for in silico analyses of retinoid metabolism and signaling
components were retrieved by reciprocal Basic Local Alignment
Search Tool (BLAST) searches from the databases implemented at
the National Center for Biotechnology Information. Species included
were the cnidarianNematostella vectensis, themollusk Lottia gigantea,
the annelid C. teleta, the amphioxus Branchiostoma floridae, the fish
Danio rerio, and humans, that is, Homo sapiens. Possible orthologs
from P. dumerilii were retrieved from transcriptome databases of the
Arendt (http://4dx.embl.de/platy/) and Jékely (49) laboratories by
reciprocal BLAST searches. Sequence alignments were initially com-
puted using MUSCLE (50) and subsequently refined manually. Phylo-
genetic analyseswere calculatedwith both themaximum likelihood (ML)
and Bayesian inference (BI) methods. The ML trees were constructed
with PhyMLv3.0 using the automated substitutionmodel selectionmode
(PhyML-SMS) (51). Tree support for theML analyses was assessed using
an approximate likelihood-ratio test (aLRT) (52). In addition, standard
bootstrap support for the ML trees was calculated in 100 replicates using
PhyML v2.4.5, as implemented in the MacGDE package, based on the
Whelan and Goldman (WAG) substitution model and taking into ac-Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018count among-site rate heterogeneity with four g-distributed categories.
The BI phylogenies were calculated using MrBayes implemented in the
TOPALi v2.5 package (53). The BI analyses were based on the WAG
substitutionmodel taking into account the among-site rate heterogeneity
with four g-distributed categories. Posterior probability support values
for the BI trees were calculated with two runs for 1,000,000 generations,
with trees saved every 100 generations and with a 25% burn-in period.
Gene cloning
The genes encoding PduRAR and PduRXR were cloned from total
RNA extracted from embryos at 48 or 75 hpf. The full-length recep-
tors were subsequently tagged with a flag tag (DYKDDDDK) in the
N-terminal domain of the receptor and cloned into the pSG5 vector.
Chimeric GAL4 LBD receptors were created by cloning the LBD of
the receptors into the pG4MpolyII vector that encodes the DNA
binding domain of the Gal4 protein (that is, amino acids 1 to 147)
(54). The PduRAR V356F mutant was constructed by replacing the
valine in position 356 by a phenylalanine by polymerase chain reaction
(PCR)–assisted, site-directedmutagenesis using the PfuDNApolymer-
ase (Promega). The Dpn I enzyme (New England Biolabs) was used to
remove the parental DNA template.
Electrophoretic mobility shift assay
Genes encoding PduRAR and PduRXR cloned in pSG5 and containing
a flag tag were used for EMSA experiments. Both receptors were trans-
lated in vitro and labeled with [35S]methionine using the TNT wheat
germ extract system (Promega), and assays were subsequently per-
formed as previously described (16).
Ligands
The ligands ATRA, 9cRA, 13cRA, BMS493 (an RAR antagonist),
BMS649 (an RXR agonist), and UVI3003 (an RXR antagonist) were
purchased from Sigma-Aldrich. Stock solutions of the different
compounds were prepared in ethanol at 10 mM.
Transactivation experiments
HEK 293T or COS (kidney from African green monkey) cells were
maintained in Dulbecco’s modified Eagle’s medium (Invitrogen by Life
Technologies), supplemented with 10% fetal calf serum (Invitrogen by
Life Technologies). Transfections and treatments were performed as
previously described (20) with 60 ng (for HEK 293T cells) or 400 ng
(for COS cells) of total DNA, and the final concentrations of the differ-
ent ligands were between 0.1 and 10 mM.
Limited proteolysis assay
Using the TNT coupled reticulocyte lysate system (Promega), the
PduRAR receptor was translated and labeled with [35S]methionine
in vitro. LPA experiments were subsequently carried out as previously
described (16), using final concentrations of the tested ligands between
0.1 and 10 mM.
Expression and purification of the PduRAR LBD
The wild-type PduRAR LBD was fused to His-thioredoxin, and the
clone was subsequently transformed into BL21(DE3) Escherichia coli
cells, which were grown at 37°C in LB medium supplemented with
ampicillin (50 mg/ml) until the OD600 (optical density at 600 nm)
reached about 0.6. The protein was overexpressed by addition of IPTG
(isopropyl-b-D-thiogalactopyranoside) to a final concentration of
0.5 mM, and the culture was supplemented with 1 mMATRA. After an12 of 16









additional incubation for 8 hours at 18°C, the culture was harvested by
centrifugation at 8000g for 20 min and stored at −80°C. Cell pellets
from a total of 4 liters of culture were resuspended in 50 ml of buffer A
[50 mM tris-HCl (pH 7.5), 500 mMNaCl, 1 mM dithiothreitol (DTT),
0.1 mM ATRA] supplemented with a protease inhibitor cocktail
(cOmplete,Mini, EDTA-free) (RocheApplied Science). The suspension
was lysed by sonication and centrifuged at 35,000g at 4°C for 45 min.
The supernatant was loaded onto a nickel affinity column (5 ml;
HisTrap) (GE Healthcare) preequilibrated with buffer A. The protein
was eluted with buffer B [50 mM tris-HCl (pH 7.5), 500 mM NaCl,
1 mM DTT, 500 mM imidazole, 0.1 mM ATRA]. The fractions con-
taining His-thioredoxin–PduRAR LBD–ATRA were pooled and
treated with 1 mg of Tobacco Etch Virus (TEV) protease per 50 mg of
PduRARLBDand incubatedat 16°Covernight.Thedigestedproteinswere
then centrifuged at 15,000g for 20min to removeTEVprotease aggregates.
The cleaved His-thioredoxin and PduRAR LBD–ATRA proteins were
further separated by immobilized metal affinity chromatography, and
the flow-through was subsequently concentrated to 20 mg/ml and pur-
ified by size exclusion chromatography (Superdex 75 HR 26/60) (GE
Healthcare), which was preequilibrated with 20 mM tris (pH 7.5), 150
mMNaCl, 5 mMDTT, 1 mM EDTA, and 0.1 mMATRA. The resulting
protein complex was concentrated to 10 mg/ml.
Fluorescence anisotropy measurements
Fluorescence anisotropy assays were performed using a Safire 2 micro-
plate reader (TECAN) with an excitation wavelength set at 470 nm and
emission measured at 530 nm. The buffer solution for the assays was as
follows: 20 mM tris-HCl (pH 7.5), 150 mMNaCl, 1 mM EDTA, 5 mM
DTT, and 10% (v/v) glycerol. The measurements were initiated at the
highest concentration of the PduRAR LBD (40 mM), and the protein
sample was successively diluted twofold with a buffer solution. For each
point of the titration curve, the protein sample was mixed with 4 nM
fluorescent peptide and 30 mM ligand (final concentrations). Binding
data were fitted using a sigmoidal dose-response model (GraphPad
Prism, GraphPad Software), assuming the stoichiometry of one peptide
per PduRAR LBD protein.
Structure determination and refinement
Crystals of the PduRAR LBD–ATRA complex were obtained in 0.2 M
sodium acetate, 0.1 M Hepes (pH 7.5), and 20% polyethylene glycol
3000 by the hanging drop crystallization method. Single crystals were
tested, and native data were collected from one crystal cryoprotected
with 30% glycerol on the ID29 beam line at the European Synchrotron
Radiation Facility in Grenoble, France. Data were analyzed for protein
contaminants using ContaMiner (55). The crystal structure of the
PduRAR LBD–ATRA complex was determined by molecular replace-
ment using MoRDa (56). MoRDa placed four molecules in the
asymmetric unit, forming two canonical nuclear receptor LBD dimers.
However, the produced molecular replacement model was too poor for
rebuilding and refinement, and molecular replacement phases were
thus used for model rebuilding with phenix_build (57). The resulting
model was refined using CCP4 ncsrefine (58), and the obtained phases
were subjected to the Buccaneer software. The mtz output file was sub-
sequently analyzed by Parrot, using fourfold noncrystallographic
symmetry. In parallel, several homology models with different ligands
and helix H12 positions were built using SWISS-MODEL. These
models were superimposed on the Buccaneer Protein Data Bank
(PDB) file and adjustedmanually to the molecule with the best electron
density (model B), using only the coot_rigid_body_fit_zone to themapsHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018of the Parrot phases. The adjusted model was then used as a template
and copied into the positions of the three other molecules in the
asymmetric unit (molecules A, C, and D). Each new model was man-
ually adjusted using coot_rigid_body_fit_zone. The Refmac program
was used to refine this model (all B factors were set initially to 70 Å2),
using 20 steps of jelly body refinement. The Phenix softwarewas used to
obtain Translation/Libration/Screw (TLS) domains from this pdb file.
These TLS domains were subsequently subjected to an analysis by the
Lorestr program, and the resulting output was further refined in Re-
fmac. The different input phases were tested by Buccaneer analyses
on the final pdb, with the best results (as judged byR and Rfree improve-
ments) having been obtained by the Lorestr phases. Parrot was run on
the Buccaneer mtz, and the resulting Parrot phases and the model
from the final Refmac refinementwere used as bases formanual adjust-
ments and automated refinements with Refmac and Phenix.
Retinoid determination
Eggs, embryos, and adult tissues were stored at −80°C until assayed.
Biological material was homogenized and subsequently extracted using
a liquid-liquid extraction approach, as previously described (4). RA iso-
mers were quantified using LC-MS/MS on anAB Sciex 5500QTRAP in
multistage-MRM (multiple reaction monitoring) mode using APCI
(atmospheric pressure chemical ionization) in positive ion mode, as
previously described (4, 25). Retinol and retinyl esters were quantified
by HPLC-UV on a Waters ACQUITY ultra-performance liquid chro-
matography system using a method that was previously described (4).
Detecting and imaging gene expression patterns
Gene expression patterns in P. dumeriliiwere assessed by whole-mount
in situ hybridization, as previously described (31). After in situ hybridiza-
tion, specimenswere stainedwithDAPI (Invitrogen byLifeTechnologies)
and immunohistochemically labeled with an acetylated a-tubulin an-
tibody (Sigma-Aldrich) to visualize larvalmorphology and nervous system
architecture (31). Developing P. dumerilii worms were subsequently
imaged either as bright-field images with a Zeiss Axio Imager micro-
scope and a Zeiss AxiocamMRc camera or as fluorescent images either
by confocal reflection microscopy (31) with a Zeiss LD LCI Plan-
Apochromat 25× 0.8Oil/Glyc/Water DIC objective on a Zeiss LSM780
NLOor by capturing the fluorescent spectra of the nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl phosphate precipitate (31) with an
Olympus UPLSAPO 60× 1.3 silicon objective on a spinning disc con-
focal system Olympus IX83 (excitation, 633 nm; reflector, 785/762 nm)
with anAndor iXon 888Ultra camera. To illustrate the complete expres-
sion patterns, z sections of bright-field images were merged with the
software Helicon Focus. We used Adobe Photoshop CS5.1 and Adobe
Illustrator CS5 to create the final figures.
Microinjection of rar and rxr MOs
WeusedMOs (GeneTools LLC) to target the start codons ofP. dumerilii
rar (rar MO: AGTTGTCTTTGGAACATTTTCAAGT) and rxr (rxr
MO: GATAACCTGCTACCCACTCCATCAC). Before ordering, the
MO target regions were validated by comparing genomic contigs and
transcriptomic data from P. dumerilii and by PCR on genomic
DNA from different P. dumerilii specimens to ensure that the selected
DNA stretches are free of single-nucleotide polymorphisms and are
characterized by low overall polymorphism levels. As negative controls,
a standard control MO (standard control MO: CCTCTTACCTCAGT-
TACAATTTATA) and 5-mismatch control MOs (rar-5mm control
MO: AGTTcTCTTTcGAAgATTTTgAAcT and rxr-5mm control13 of 16









MO: GATAACgTcCTAgCCAgTgCATCAC) were used. A 1 mM
stock solution was prepared according to themanufacturer’s instruc-
tions and subsequently filtered (0.22 mm). Unless otherwise indi-
cated, a final MO concentration of 0.6 mM was used. The MOs were
coinjected with a fluorescent tracer, either tetramethylrhodamine-
dextran (Molecular Probes) or h2b-rfp mRNA, to visualize injected
embryos. MOs were injected into the zygote on an inverted Zeiss
Axiovert 40C microscope with self-pulled needles [borosilicate, thin
wall with filament, 1.0 mm outside diameter (OD), 0.78 mm inside
diameter (ID), 150mm length (L)] (Harvard Apparatus) using a Fem-
toJet microinjector (Eppendorf) (settings: injection pressure, 300 hPa;
injection pulse, 0.1 s; compensation pressure, 30 hPa). Needles were
pulled on a Sutter Instrument P-97 Pipette Puller using the following
settings: heat, 548; pull, 40; velocity, 130; time, 120; pressure, 500. Injec-
tions were carried out in a 16°C room, and injected embryos were
cultured at 18°C. Developing P. dumerilii worms were subsequently
fixed in 4% paraformaldehyde for further analysis. Specificity of the
MOs was assessed in vivo. The MO target region was cloned upstream
of a fluorescent tracer, h2b-egfp:pCS2+. The mRNA was transcribed in
vitro using the mMESSAGE mMACHINE SP6 Transcription Kit (Life
Technologies) and subsequently coinjected, at a final concentration of
200 ng/ml, with the corresponding MO (with or without mismatches)
and with h2b-rfpmRNA, at a final concentration of 120 ng/ml, to visu-
alize injected embryos.
Microinjection of rar mRNA
Full-length P. dumerilii rar was cloned either directly into pCS2+ or
downstream of the fluorescent tracer Lyn-mCherry separated by a
T2A self-cleaving peptide, resulting in two separate proteins upon
translation. The fusion protein was inserted into pCS2+. The mRNAs
were prepared as indicated above and injected at final concentrations of
220 to 400 ng/ml using the setup described above. The first rarmRNA
was coinjectedwith a fluorescent tracer, tetramethylrhodamine-dextran
(Molecular Probes), to visualize injected embryos. Embryos were
fixed at 41 or 48 hpf in 4% paraformaldehyde and were subsequently
immunostained. Before these experiments, we validated that the
T2A peptide of the second mRNA construct is self-cleaving in P.
dumerilii by injecting the mRNA of a fusion protein with two dif-
ferent fluorescent markers (Lyn-mCherry-T2A-H2B-GFP) into the
P. dumerilii zygote.
Retinoid pharmacology
DevelopingP. dumeriliiwormswere treatedwithATRAor 13cRA from
12 to 24 hpf, 34 to 40 hpf, 48 to 80 hpf, and 96 to 102 hpf. ATRA and
13cRA stock solutions (10 mM) were prepared in DMSO, aliquoted
into amber tubes (Eppendorf), and stored at −80°C. The stock solution
aliquots were defrosted and used only once. Drug treatments were per-
formed in six-well plates in 6 ml of filtered (0.22 mm) natural seawater
(NSW). NSW (3 ml) with 100 to 200 embryos was added to each well.
The RA dilutions were prepared andmixed by vortexing in the remain-
ing 3 ml of NSW before addition to the embryos. The final concentra-
tions of the treatments were as follows: 1, 2, 4, 5, 8, and 10 mM. DMSO
treatments were used as controls. After treatment, the six-well plate was
covered with aluminum foil to avoid light exposure. Embryos were sub-
sequently cultured at 18°C. At the end of the drug treatment, embryos
were washed in NSW and fixed in 4% paraformaldehyde for further
analysis. EdU labeling was performed before fixation and following
the manufacturer’s instructions (Invitrogen). The swimming behavior
of P. dumerilii prelarvae and larvae, treated with ATRA or 13cRA, wasHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018recorded, respectively, with a Nikon Digital Sight DS-Fi1 camera and a
DMK 42BUC03 camera (25 frames per second; The Imaging Source)
and subsequently tracked with the Fiji plug-ins TrackMate (59) and
MTrackJ (60).SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/2/eaao1261/DC1
fig. S1. Phylogenetic analyses of the molecular components of retinoid metabolism and
signaling in P. dumerilii.
fig. S2. Alignment of RAR sequences.
fig. S3. Transactivation assays using the PduRXR.
fig. S4. Structural analysis of the LBD of the PduRAR.
fig. S5. Expression of RA metabolic enzymes (aldh1a and cyp26) in P. dumerilii.
fig. S6. Validation of MOs for microinjection into P. dumerilii zygotes.
fig. S7. Effects of ATRA and 13cRA treatments on P. dumerilii larval development.
table S1. Data collection and refinement statistics for the PduRAR LBD–ATRA crystal structure
complex.
movie S1. Locomotion of P. dumerilii larvae upon application of exogenous RA.
movie S2. Locomotion of P. dumerilii prelarvae upon application of exogenous RA.
References (61, 62)REFERENCES AND NOTES
1. K. Niederreither, P. Dollé, Retinoic acid in development: Towards an integrated view.
Nat. Rev. Genet. 9, 541–553 (2008).
2. T. J. Cunningham, G. Duester, Mechanisms of retinoic acid signalling and its roles in
organ and limb development. Nat. Rev. Mol. Cell Biol. 16, 110–123 (2015).
3. J. L. Napoli, Physiological insights into all-trans-retinoic acid biosynthesis. Biochim.
Biophys. Acta. 1821, 152–167 (2012).
4. M. A. Kane, J. L. Napoli, Quantification of endogenous retinoids. Methods Mol. Biol. 652,
1–54 (2010).
5. P. Chambon, A decade of molecular biology of retinoic acid receptors. FASEB J. 10,
940–954 (1996).
6. J. E. Balmer, R. Blomhoff, A robust characterization of retinoic acid response elements
based on a comparison of sites in three species. J. Steroid Biochem. Mol. Biol. 96,
347–354 (2005).
7. A. Chatagnon, P. Veber, V. Morin, J. Bedo, G. Triqueneaux, M. Sémon, V. Laudet,
F. d’Alché-Buc, G. Benoit, RAR/RXR binding dynamics distinguish pluripotency from
differentiation associated cis-regulatory elements. Nucleic Acids Res. 43, 4833–4854 (2015).
8. P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera,
R. Lotan, D. J. Mangelsdorf, H. Gronemeyer, International Union of Pharmacology.
LX. Retinoic acid receptors. Pharmacol. Rev. 58, 712–725 (2006).
9. H. Gronemeyer, J.-Å. Gustafsson, V. Laudet, Principles for modulation of the nuclear
receptor superfamily. Nat. Rev. Drug Discov. 3, 950–964 (2004).
10. M. A. Mendoza-Parra, M. Walia, M. Sankar, H. Gronemeyer, Dissecting the retinoid-
induced differentiation of F9 embryonal stem cells by integrative genomics. Mol. Syst.
Biol. 7, 538 (2011).
11. E. Moutier, T. Ye, M.-A. Choukrallah, S. Urban, J. Osz, A. Chatagnon, L. Delacroix, D. Langer,
N. Rochel, D. Moras, G. Benoit, I. Davidson, Retinoic acid receptors recognize the mouse
genome through binding elements with diverse spacing and topology. J. Biol. Chem. 287,
26328–26341 (2012).
12. F. Campo-Paysaa, F. Marlétaz, V. Laudet, M. Schubert, Retinoic acid signaling in development:
Tissue-specific functions and evolutionary origins. Genesis 46, 640–656 (2008).
13. R. Albalat, C. Cañestro, Identification of Aldh1a, Cyp26 and RAR orthologs in protostomes
pushes back the retinoic acid genetic machinery in evolutionary time to the bilaterian
ancestor. Chem. Biol. Interact. 178, 188–196 (2009).
14. N. I. Bakalenko, A. V. Poznyak, E. L. Novikova, M. A. Kulakova, Effect of retinoids on Post2 Hox
gene expression in nereid polychaetes. Russ. J. Dev. Biol. 48, 211–218 (2017).
15. H. Urushitani, Y. Katsu, Y. Ohta, H. Shiraishi, T. Iguchi, T. Horiguchi, Cloning and
characterization of the retinoic acid receptor-like protein in the rock shell, Thais clavigera.
Aquat. Toxicol. 142–143, 403–413 (2013).
16. J. Gutierrez-Mazariegos, E. K. Nadendla, D. Lima, K. Pierzchalski, J. W. Jones, M. Kane,
J.-I. Nishikawa, Y. Hiromori, T. Nakanishi, M. M. Santos, L. F. C. Castro, W. Bourguet,
M. Schubert, V. Laudet, A mollusk retinoic acid receptor (RAR) ortholog sheds light on
the evolution of ligand binding. Endocrinology 155, 4275–4286 (2014).
17. A. H. L. Fischer, T. Henrich, D. Arendt, The normal development of Platynereis dumerilii
(Nereididae, Annelida). Front. Zool. 7, 31 (2010).14 of 16









18. R. Albalat, F. Brunet, V. Laudet, M. Schubert, Evolution of retinoid and steroid signaling:
Vertebrate diversification from an amphioxus perspective. Genome Biol. Evol. 3, 985–1005
(2011).
19. J.-P. Renaud, N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, D. Moras, Crystal
structure of the RAR-g ligand-binding domain bound to all-trans retinoic acid. Nature
378, 681–689 (1995).
20. H. Escriva, S. Bertrand, P. Germain, M. Robinson-Rechavi, M. Umbhauer, J. Cartry,
M. Duffraisse, L. Holland, H. Gronemeyer, V. Laudet, Neofunctionalization in vertebrates:
The example of retinoic acid receptors. PLOS Genet. 2, e102 (2006).
21. P. Germain, J. Iyer, C. Zechel, H. Gronemeyer, Co-regulator recruitment and the
mechanism of retinoic acid receptor synergy. Nature 415, 187–192 (2002).
22. P. F. Egea, A. Mitschler, D. Moras, Molecular recognition of agonist ligands by RXRs.
Mol. Endocrinol. 16, 987–997 (2002).
23. V. Nahoum, E. Pérez, P. Germain, F. Rodríguez-Barrios, F. Manzo, S. Kammerer, G. Lemaire,
O. Hirsch, C. A. Royer, H. Gronemeyer, A. R. de Lera, W. Bourguet, Modulators of the
structural dynamics of the retinoid X receptor to reveal receptor function. Proc. Natl.
Acad. Sci. U.S.A. 104, 17323–17328 (2007).
24. A. le Maire, C. Teyssier, C. Erb, M. Grimaldi, S. Alvarez, A. R. de Lera, P. Balaguer,
H. Gronemeyer, C. A. Royer, P. Germain, W. Bourguet, A unique secondary-structure
switch controls constitutive gene repression by retinoic acid receptor. Nat. Struct.
Mol. Biol. 17, 801–807 (2010).
25. J. W. Jones, K. Pierzchalski, J. Yu, M. A. Kane, Use of fast HPLC multiple reaction
monitoring cubed for endogenous retinoic acid quantification in complex matrices.
Anal. Chem. 87, 3222–3230 (2015).
26. M. A. Kane, Analysis, occurrence, and function of 9-cis-retinoic acid. Biochim. Biophys. Acta
1821, 10–20 (2012).
27. R. Blomhoff, H. K. Blomhoff, Overview of retinoid metabolism and function.
Dev. Neurobiol. 66, 606–630 (2006).
28. G. Begemann, T. F. Schilling, G.-J. Rauch, R. Geisler, P. W. Ingham, The zebrafish neckless
mutation reveals a requirement for raldh2 in mesodermal signals that pattern the
hindbrain. Development 128, 3081–3094 (2001).
29. A. S. Denes, G. Jékely, P. R. H. Steinmetz, F. Raible, H. Snyman, B. Prud’homme,
D. E. K. Ferrier, G. Balavoine, D. Arendt, Molecular architecture of annelid nerve cord
supports common origin of nervous system centralization in Bilateria. Cell 129, 277–288
(2007).
30. J. N. Rosen, M. F. Sweeney, J. D. Mably, Microinjection of zebrafish embryos to analyze
gene function. J. Vis. Exp. e1115 (2009).
31. G. Jékely, D. Arendt, Cellular resolution expression profiling using confocal detection
of NBT/BCIP precipitate by reflection microscopy. Biotechniques 42, 751–755
(2007).
32. S. Arber, B. Han, M. Mendelsohn, M. Smith, T. M. Jessell, S. Sockanathan, Requirement for
the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23,
659–674 (1999).
33. M. Kulakova, N. Bakalenko, E. Novikova, C. E. Cook, E. Eliseeva, P. R. H. Steinmetz,
R. P. Kostyuchenko, A. Dondua, D. Arendt, M. Akam, T. Andreeva, Hox gene expression in
larval development of the polychaetes Nereis virens and Platynereis dumerilii (Annelida,
Lophotrochozoa). Dev. Genes Evol. 217, 39–54 (2007).
34. J. Gutierrez-Mazariegos, “Evolution of the retinoic acid receptor,” thesis, Ecole Normale
Supérieure de Lyon (2014).
35. S. G. Mansfield, S. Cammer, S. C. Alexander, D. P. Muehleisen, R. S. Gray, A. Tropsha,
W. E. Bollenbacher, Molecular cloning and characterization of an invertebrate cellular
retinoic acid binding protein. Proc. Natl. Acad. Sci. U.S.A. 95, 6825–6830 (1998).
36. I. Söderhäll, A. Tangprasittipap, H. Liu, K. Sritunyalucksana, P. Prasertsan,
P. Jiravanichpaisal, K. Söderhäll, Characterization of a hemocyte intracellular fatty acid-
binding protein from crayfish (Pacifastacus leniusculus) and shrimp (Penaeus monodon).
FEBS J. 273, 2902–2912 (2006).
37. R. J. White, Q. Nie, A. D. Lander, T. F. Schilling, Complex regulation of cyp26a1
creates a robust retinoic acid gradient in the zebrafish embryo. PLOS Biol. 5, e304
(2007).
38. Z. Kostrouch, M. Kostrouchova, W. Love, E. Jannini, J. Piatigorsky, J. E. Rall, Retinoic acid
X receptor in the diploblast, Tripedalia cystophora. Proc. Natl. Acad. Sci. U.S.A. 95,
13442–13447 (1998).
39. B. Fuchs, W. Wang, S. Graspeuntner, Y. Li, S. Insua, E.-M. Herbst, P. Dirksen, A.-M. Böhm,
G. Hemmrich, F. Sommer, T. Domazet-Lošo, U. C. Klostermeier, F. Anton-Erxleben,
P. Rosenstiel, T. C. G. Bosch, K. Khalturin, Regulation of polyp-to-jellyfish transition in
Aurelia aurita. Curr. Biol. 24, 263–273 (2014).
40. M. Bouzaiene, A. Angers, M. Anctil, Immunohistochemical localization of a retinoic
acid-like receptor in nerve cells of two colonial anthozoans (Cnidaria). Tissue Cell 39,
123–130 (2007).
41. D. Estephane, M. Anctil, Retinoic acid and nitric oxide promote cell proliferation and
differentially induce neuronal differentiation in vitro in the cnidarian Renilla koellikeri.
Dev. Neurobiol. 70, 842–852 (2010).Handberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 201842. R. Pennati, A. Dell’Anna, G. Zega, F. De Bernardi, S. Piraino, Retinoic acid influences
antero‐posterior positioning of peptidergic neurons in the planula larva of the hydrozoan
Clava multicornis. Mar. Ecol. 34, 143–152 (2013).
43. C. J. Carter, N. Farrar, R. L. Carlone, G. E. Spencer, Developmental expression of a
molluscan RXR and evidence for its novel, nongenomic role in growth cone guidance.
Dev. Biol. 343, 124–137 (2010).
44. M. Maden, G. Keen, G. E. Jones, Retinoic acid as a chemotactic molecule in neuronal
development. Int. J. Dev. Neurosci. 16, 317–322 (1998).
45. J. M. Dmetrichuk, G. E. Spencer, R. L. Carlone, Retinoic acid-dependent attraction of adult
spinal cord axons towards regenerating newt limb blastemas in vitro. Dev. Biol. 281,
112–120 (2005).
46. A. Janesick, S. C. Wu, B. Blumberg, Retinoic acid signaling and neuronal differentiation.
Cell. Mol. Life Sci. 72, 1559–1576 (2015).
47. A. Linville, K. Radtke, J. S. Waxman, D. Yelon, T. F. Schilling, Combinatorial roles for
zebrafish retinoic acid receptors in the hindbrain, limbs and pharyngeal arches. Dev. Biol.
325, 60–70 (2009).
48. J. S. Dasen, T. M. Jessell, Hox networks and the origins of motor neuron diversity.
Curr. Top. Dev. Biol. 88, 169–200 (2009).
49. M. Conzelmann, E. A. Williams, K. Krug, M. Franz-Wachtel, B. Macek, G. Jékely, The
neuropeptide complement of the marine annelid Platynereis dumerilii. BMC Genomics 14,
906 (2013).
50. R. C. Edgar, MUSCLE: Multiple sequence alignment with high accuracy and high
throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
51. S. Guindon, J.-F. Dufayard, V. Lefort, M. Anisimova, W. Hordijk, O. Gascuel, New algorithms
and methods to estimate maximum-likelihood phylogenies: Assessing the performance
of PhyML 3.0. Syst. Biol. 59, 307–321 (2010).
52. M. Anisimova, O. Gascuel, Approximate likelihood-ratio test for branches: A fast, accurate,
and powerful alternative. Syst. Biol. 55, 539–552 (2006).
53. I. Milne, F. Wright, G. Rowe, D. F. Marshall, D. Husmeier, G. McGuire, TOPALi: Software for
automatic identification of recombinant sequences within DNA multiple alignments.
Bioinformatics 20, 1806–1807 (2004).
54. G. Allenby, M. T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey,
P. Kastner, J. F. Grippo, P. Chambon, Retinoic acid receptors and retinoid X receptors:
Interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. U.S.A. 90, 30–34 (1993).
55. A. Hungler, A. Momin, K. Diederichs, S. T. Arold, ContaMiner and ContaBase: A webserver
and database for early identification of unwantedly crystallized protein contaminants.
J. Appl. Crystallogr. 49, 2252–2258 (2016).
56. A. Vagin, A. Lebedev, MoRDa, an automatic molecular replacement pipeline.
Acta Crystallogr. A 71, s19 (2015).
57. P. D. Adams, D. Baker, A. T. Brunger, R. Das, F. DiMaio, R. J. Read, D. C. Richardson,
J. S. Richardson, T. C. Terwilliger, Advances, interactions, and future developments in the
CNS, Phenix, and Rosetta structural biology software systems. Annu. Rev. Biophys. 42,
265–287 (2013).
58. Collaborative Computational Project, Number 4, The CCP4 suite: Programs for protein
crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994).
59. J.-Y. Tinevez, N. Perry, J. Schindelin, G. M. Hoopes, G. D. Reynolds, E. Laplantine,
S. Y. Bednarek, S. L. Shorte, K. W. Eliceiri, TrackMate: An open and extensible platform for
single-particle tracking. Methods 115, 80–90 (2017).
60. E. Meijering, O. Dzyubachyk, I. Smal, Methods for cell and particle tracking. Methods
Enzymol. 504, 183–200 (2012).
61. M. Gouy, S. Guindon, O. Gascuel, SeaView version 4: A multiplatform graphical user
interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27,
221–224 (2010).
62. M. Kearse, R. Moir, A. Wilson, S. Stones-Havas, M. Cheung, S. Sturrock, S. Buxton, A. Cooper,
S. Markowitz, C. Duran, T. Thierer, B. Ashton, P. Meintjes, A. Drummond, Geneious Basic:
An integrated and extendable desktop software platform for the organization and analysis of
sequence data. Bioinformatics 28, 1647–1649 (2012).
Acknowledgments: We are indebted to N. Robert, M. Sémon, O. Simakov, and T. Larsson
for help with bioinformatic analyses. K. Achim, P. Mejstrik, and G. Holzer supported
pharmacological treatments, whole-mount in situ hybridization experiments, and
transactivation assays, respectively. We also thank S. P. Singh for providing plasmids and
K. Skouloudaki for discussions. Funding: This work was financed by the European Molecular
Biology Laboratory (to M.H.-T., P.Y.B., and D.A.), the Ministerio de Ciencia e Innovación
(ES-2008-236 to M.H.-T. and BFU2010-14875 to R.A.), the European Research Council (HOURGLASS
no. 260746 to M.H.-T. and P.T. and BrainEvoDevo no. 294810 to P.Y.B. and D.A.), the King
Abdullah University of Science and Technology (to S.T.A.), the Ministerio de Economía y
Competitividad (BIO2015-67358-C2-1-P to R.A.), the French Infrastructure for Integrated
Structural Biology program (ANR-10-INBS-05 to W.B.), and the Agence Nationale de la
Recherche (ANR-11-JSV2-002-01 to M.S.). Author contributions: M.H.-T. and J.G.-M. screened
sequence databases for P. dumerilii genes, which were cloned by M.H.-T. J.G.-M. and P.G.
performed in vitro studies. S.T.A., E.K.N., and W.B. obtained the PduRAR crystal and solved the15 of 16
SC I ENCE ADVANCES | R E S EARCH ART I C L Ecrystal structure. S.T.A., P.G., and W.B. refined and analyzed the crystal structure. R.A.
performed phylogenetic calculations, with support from M.H.-T., J.G.-M., and M.S. K.P., J.W.J.,
and M.A.K. carried out retinoid content analyses on material collected by M.H.-T. and
J.G.-M. M.H.-T. performed microinjections and, together with P.Y.B., pharmacological
treatments. M.H.-T., P.Y.B., and P.T. carried out whole-mount in situ hybridization and
immunohistochemistry experiments. M.H.-T., J.G.-M., V.L., D.A., and M.S. designed the study
and analyzed data. M.H.-T., V.L., D.A., and M.S. wrote the manuscript. M.H.-T. and M.S. finalized
figures, tables, and text. All authors commented on the manuscript and agreed to its final
version. Competing interests: The authors declare that they have no competing interests.
Data and material availability: All data needed to evaluate the conclusions in this study
are presented in the paper and/or the Supplementary Materials. Additional data related to this
paper may be requested from the authors. The P. dumerilii sequences have been deposited in theHandberg-Thorsager et al., Sci. Adv. 2018;4 : eaao1261 21 February 2018GenBank nucleotide database with accession numbers KY679090 to KY679137. The PduRAR
crystal structure has been submitted to the PDB archive, with the PDB ID 6EU9.
Submitted 19 June 2017
Accepted 10 January 2018
Published 21 February 2018
10.1126/sciadv.aao1261
Citation: M. Handberg-Thorsager, J. Gutierrez-Mazariegos, S. T. Arold, E. Kumar Nadendla,
P. Y. Bertucci, P. Germain, P. Tomançak, K. Pierzchalski, J. W. Jones, R. Albalat, M. A. Kane,
W. Bourguet, V. Laudet, D. Arendt, M. Schubert, The ancestral retinoic acid receptor was a










The ancestral retinoic acid receptor was a low-affinity sensor triggering neuronal
Laudet, Detlev Arendt and Michael Schubert
Germain, Pavel Tomançak, Keely Pierzchalski, Jace W. Jones, Ricard Albalat, Maureen A. Kane, William Bourguet, Vincent 
Mette Handberg-Thorsager, Juliana Gutierrez-Mazariegos, Stefan T. Arold, Eswar Kumar Nadendla, Paola Y. Bertucci, Pierre
DOI: 10.1126/sciadv.aao1261






This article cites 60 articles, 8 of which you can access for free
PERMISSIONS http://www.sciencemag.org/help/reprints-and-permissions
Terms of ServiceUse of this article is subject to the 
registered trademark of AAAS.
is aScience Advances Association for the Advancement of Science. No claim to original U.S. Government Works. The title 
York Avenue NW, Washington, DC 20005. 2017 © The Authors, some rights reserved; exclusive licensee American 
(ISSN 2375-2548) is published by the American Association for the Advancement of Science, 1200 NewScience Advances 
 on M
ay 8, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
